VIR Q4 Earnings Beat on Higher Revenues From Covid Treatment
25/2 18:49
Vir Biotechnology VIR reported earnings of $3.92 per share in the fourth quarter, beating the Zacks Consensus Estimate of $2.60. In the year-ago quarter, the company reported a loss of 83 cents due to lower revenues....